Randomized, Double-blind, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia.

Trial Profile

Randomized, Double-blind, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jul 2011

At a glance

  • Drugs Piromelatine (Primary)
  • Indications Insomnia
  • Focus Adverse reactions
  • Acronyms MAD
  • Most Recent Events

    • 06 Apr 2011 Actual end date (1 Apr 2011) added as reported by ClinicalTrials.gov.
    • 06 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Dec 2010 Planned end date changed from 1 Nov 2010 to 1 Apr 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top